Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Prevalence and Incidence

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.

Journal of medicinal chemistry·2010

Same author

Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells.

Cardiovascular research·2010

Same author

In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides.

Peptides·2010

Same author

[Detection of single-walled carbon nanotube bundles by tip-enhanced Raman spectroscopy].

Guang pu xue yu guang pu fen xi = Guang pu·2009

Same author

Calcium-sensing receptors induce apoptosis in rat cardiomyocytes via the endo(sarco)plasmic reticulum pathway during hypoxia/reoxygenation.

Basic & clinical pharmacology & toxicology·2009

Same author

Evolution of the solvent polarity in an electrospray plume.

Journal of the American Society for Mass Spectrometry·2009

Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026

Same journal

Acknowledgment of Referees 2025.

Biometrics·2026

Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026

Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026

Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026

Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

Augmented cross-sectional prevalence testing for estimating HIV incidence.

Rui Wang¹, Stephen W Lagakos

¹Department of Biostatistics, Harvard University School of Public Health, Boston, Massachusetts 02115, USA. rwang@hsph.harvard.edu

|November 17, 2009

Summary

This summary is machine-generated.

This study introduces an improved cross-sectional method for estimating HIV incidence, addressing limitations of previous approaches. The new design enhances accuracy by tracking recent infections and removing the need for external window period estimations.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Related Experiment Videos

Last Updated: Jun 18, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Area of Science:

Epidemiology
Biostatistics

Background:

Cross-sectional studies offer advantages for estimating HIV incidence compared to longitudinal studies.
Previous cross-sectional methods faced challenges with external window period approximations and handling false negatives.

Purpose of the Study:

To propose and evaluate an augmented cross-sectional design for more reliable HIV incidence estimation.
To overcome limitations of existing methods, specifically the need for external window period data and managing false negatives.

Main Methods:

An augmented cross-sectional design is introduced, following individuals in the recent infection state to track transitions.
Likelihood methods are employed, accounting for length-biased window periods and forward recurrence times.
The approach integrates recent infection state transitions into the estimation model.

Main Results:

Simulation studies demonstrate the effectiveness of the proposed augmented design.
The method successfully eliminates the requirement for external approximations of the mean window period.
It also addresses the issue of false negative results from less-sensitive diagnostic tests.

Conclusions:

The augmented cross-sectional design provides a more robust and reliable method for HIV incidence estimation.
This approach simplifies the estimation process by removing reliance on external parameters.
The findings have significant implications for public health surveillance of HIV infection rates.